Previous close | 1.0700 |
Open | 1.0800 |
Bid | 0.7704 x 200 |
Ask | 1.3900 x 200 |
Day's range | 1.0300 - 1.0800 |
52-week range | 0.9800 - 23.8000 |
Volume | |
Avg. volume | 115,754 |
Market cap | 1.577M |
Beta (5Y monthly) | 2.88 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SAN FRANCISCO, March 25, 2024--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its financial results for the year ending December 31, 2023.
SAN FRANCISCO, March 19, 2024--Tivic Health® Systems, Inc. ("Tivic Health") (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will report its year-end financial results for 2023 via pre-recorded conference call and webcast on Monday, March 25, 2024 at 1:30 PM PT / 4:30 PM ET.
SAN FRANCISCO, February 21, 2024--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that enrollment in its pilot clinical study of a proprietary approach to non-invasive vagus nerve stimulation (VNS) has been completed.